Anika Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Anika Therapeutics, Inc. (ANIK) reported Increase (Decrease) in Other Operating Assets of -$101.99 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2014-11-06
- Anika Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2013-12-31 was -$76.49K.
- Anika Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2013-09-30 was -$8.50K.
- Anika Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2013-06-30 was -$8.50K.
- Anika Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2013-03-31 was -$8.50K.
- Anika Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2013 was -$101.99K.
- Anika Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2012 was -$33.99K.
- Anika Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2011 was -$179.94K.
- Anika Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2010 was -$28.24K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2013-12-31 | -$76.49K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$84.99K derived: sum of 2 quarters · filed 2014-11-06 | -$93.49K derived: sum of 3 quarters · filed 2014-11-06 | -$101.99K 10-K · filed 2014-03-13 |
| 2013-09-30 | -$8.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$17.00K derived: sum of 2 quarters · filed 2014-11-06 | -$25.50K 10-Q · filed 2014-11-06 | -$34.00K derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | -$8.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$17.00K 10-Q · filed 2014-08-04 | -$25.50K derived: sum of 3 quarters · filed 2014-08-04 | -$34.00K derived: sum of 4 quarters · filed 2014-08-04 |
| 2013-03-31 | -$8.50K 10-Q · filed 2014-05-05 | -$17.00K derived: sum of 2 quarters · filed 2014-05-05 | -$25.50K derived: sum of 3 quarters · filed 2014-05-05 | -$33.99K derived: sum of 4 quarters · filed 2014-05-05 |
| 2012-12-31 | -$8.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$17.00K derived: sum of 2 quarters · filed 2014-03-13 | -$25.50K derived: sum of 3 quarters · filed 2014-03-13 | -$33.99K 10-K · filed 2014-03-13 |
| 2012-09-30 | -$8.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$17.00K derived: sum of 2 quarters · filed 2013-11-05 | -$25.50K 10-Q · filed 2013-11-05 | -$42.44K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | -$8.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$17.00K 10-Q · filed 2013-08-06 | -$33.94K derived: sum of 3 quarters · filed 2014-03-13 | -$179.94K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | -$8.50K 10-Q · filed 2013-05-06 | -$25.44K derived: sum of 2 quarters · filed 2014-03-13 | -$171.44K derived: sum of 3 quarters · filed 2014-03-13 | -$179.94K derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | -$16.94K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$162.94K derived: sum of 2 quarters · filed 2014-03-13 | -$171.44K derived: sum of 3 quarters · filed 2014-03-13 | -$179.94K 10-K · filed 2014-03-13 |
| 2011-09-30 | -$146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$154.50K derived: sum of 2 quarters · filed 2012-11-08 | -$163.00K 10-Q · filed 2012-11-08 | -$175.15K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-06-30 | -$8.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$17.00K 10-Q · filed 2012-08-07 | -$29.15K derived: sum of 3 quarters · filed 2013-03-14 | -$37.69K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-03-31 | -$8.50K 10-Q · filed 2012-05-07 | -$20.65K derived: sum of 2 quarters · filed 2013-03-14 | -$29.19K derived: sum of 3 quarters · filed 2013-03-14 | |
| 2010-12-31 | -$12.15K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | -$20.69K derived: sum of 2 quarters · filed 2013-03-14 | -$28.24K 10-K · filed 2013-03-14 | |
| 2010-09-30 | -$8.54K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-04 | -$16.09K 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | -$7.55K 10-Q/A · filed 2011-08-10 | |||
| 2009-12-31 | -$93.56K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |